1. |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
|
2. |
Ohashi K, Shibata R, Murohara T, et al. Role of anti-inflammatory adipokines in obesity-related diseases. Trends Endocrinol Metab, 2014, 25(7): 348-355.
|
3. |
Kazama K, Usui T, Okada M, et al. Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol, 2012, 686(1-3): 116-123.
|
4. |
慢性阻塞性肺疾病急性加重(AECOPD) 诊治专家组. 慢性阻塞性肺疾病急性加重 (AECOPD) 诊治中国专家共识 (2017 年更新版). 国际呼吸杂志, 2017, 37(14): 1041-1057.
|
5. |
Richmond BW, Du RH, Han W, et al. Bacterial-derived neutrophilic inflammation drives lung remodeling in a mouse model of COPD. Am J Respir Cell Mol Biol, 2018, 58(6): 736-744.
|
6. |
Polosukhin VV, Richmond BW, Du RH, et al. Secretory IgA Deficiency in individual small airways is associated with persistent inflammation and remodeling. Am J Respir Crit Care Med, 2017, 195(8): 1010-1021.
|
7. |
Zhang DM, Pang XL, Huang R, et al. Adiponectin, omentin, ghrelin, and visfatin levels in obese patients with severe obstructive sleep apnea. Biomed Res Int, 2018, 2018: 3410135.
|
8. |
Zhou Y, Zhang B, Hao C, et al. Omentin--a novel adipokine in respiratory diseases. Int J Mol Sci, 2017, 19(1): E73.
|
9. |
Kataoka Y, Shibata R, Ohashi K, et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase-and Akt-dependent mechanisms. J Am Coll Cardiol, 2014, 63(24): 2722-2733.
|
10. |
Mancuso P. Obesity and lung inflammation. J Appl Physiol, 2010, 108(3): 722-728.
|
11. |
Yan P, Liu D, Long M, et al. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes, 2011, 119(4): 257-263.
|
12. |
Wang C. Obesity, inflammation, and lung injury (OILI): the good. Mediators Inflamm, 2014, 2014: 978463.
|